Obesity Management

Medical weight management to improve sleep apnea and overall health

About This Service

As part of our comprehensive approach to obstructive sleep apnea care, we offer medical weight management services. Excess weight is a leading contributor to sleep apnea, and meaningful weight loss can significantly improve symptoms and reduce disease severity. We prescribe GLP-1 and GIP receptor agonist medications that have been shown to support substantial, sustained weight loss when combined with lifestyle modifications. Notably, Zepbound (tirzepatide) is FDA-approved for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity, making it the first medication approved specifically to address OSA. In clinical trials, patients treated with tirzepatide experienced significant reductions in apnea-hypopnea index (AHI) events and meaningful weight loss compared to placebo.

Source: FDA approves first medication to reduce severity of obstructive sleep apnea in adults (FDA.gov, Dec 2024)

Who Should Consider This Service

Patients with obesity, particularly those whose weight contributes to obstructive sleep apnea or other pulmonary conditions. This service is also appropriate for patients who have not achieved adequate weight loss through diet and exercise alone and may benefit from medication-assisted treatment.